Form 4: NIKE COO Alagirisamy Receives Significant Equity Grants

NIKE's Chief Operating Officer, Venkatesh Alagirisamy, was granted 36,645 restricted stock units and 17,615 stock options under the company's incentive plan.

Summary

• Venkatesh Alagirisamy, EVP: Chief Operating Officer of NIKE, Inc., received equity grants on December 10, 2025.
• This includes 5,429 Restricted Stock Units (RSUs) which will vest 25% annually on September 1, 2026, September 1, 2027, September 1, 2028, and September 1, 2029.
• An additional 31,216 Performance-Based Restricted Stock Units were granted, which will vest on December 10, 2027, the second anniversary of the grant date.
• Alagirisamy also received 17,615 Non-Qualified Stock Options with an exercise price of $65.79, which become exercisable 25% annually on September 1, 2026, September 1, 2027, September 1, 2028, and September 1, 2029, and expire on December 10, 2035.
• These transactions were made pursuant to a Rule 10b5-1(c) plan.
• Following these transactions, Alagirisamy beneficially owns 86,040 Class B Common Stock (non-derivative) and 17,615 derivative stock options.

Sentiment

Score: 7

Explanation: The filing indicates routine executive compensation through equity grants, which is a positive for aligning management incentives with shareholder interests. It reflects standard corporate practice and a commitment to long-term executive retention and performance.

Positives

• Significant equity grants align executive interests with shareholder value.
• The grants include performance-based RSUs, linking a portion of compensation directly to company performance.
• The stock options have a 10-year expiration, providing a long-term incentive for the executive.
• The use of a Rule 10b5-1(c) plan indicates pre-planned transactions, reducing concerns about opportunistic insider trading.

Negatives

• No immediate cash proceeds for the executive as these are grants, not sales of existing shares.
• The multi-year vesting schedules mean the full benefit of the grants is not immediate.

Future Outlook

The filing details future vesting schedules for RSUs and stock options, indicating that a significant portion of the executive's compensation is tied to future company performance and stock price appreciation over the next several years, with vesting extending through September 2029 and options expiring in December 2035.

Industry Context

Executive equity grants are a standard practice in publicly traded companies across various industries, including apparel and footwear, to incentivize long-term performance and align management interests with shareholders. These grants are typical for senior executives at companies like NIKE.

Comparison to Industry Standards

• The structure of RSU and stock option grants with multi-year vesting schedules is a common practice for executive compensation in large, established companies like NIKE, similar to practices seen at competitors such as Adidas, Under Armour, or Lululemon.
• The inclusion of performance-based RSUs is a strong corporate governance practice, aligning executive incentives with specific company performance targets, a trend observed across leading global corporations.
• The option exercise price of $65.79 would typically be compared to NIKE's stock price on the grant date (12/10/2025) to assess if they were granted at-the-money, in-the-money, or out-of-the-money, which is standard practice in executive compensation.

Stakeholder Impact

• Shareholders: Aligns executive incentives with shareholder value creation through equity ownership and performance-based vesting.
• Employees: Standard executive compensation practices can set a precedent or benchmark for other employee incentive programs.
• Management: Provides long-term incentives and retention for a key executive.

Next Steps

• Vesting of 5,429 RSUs on 09/01/2026, 09/01/2027, 09/01/2028, and 09/01/2029.
• Vesting of 31,216 Performance-Based RSUs on 12/10/2027.
• Stock options become exercisable on 09/01/2026, 09/01/2027, 09/01/2028, and 09/01/2029.
• Expiration of stock options on 12/10/2035.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation through equity grants and does not contain information that would fundamentally alter the investment thesis for NIKE. It reflects standard corporate governance and incentive alignment practices. While positive for executive retention and motivation, it is not a catalyst for a 'buy' or 'sell' recommendation on its own. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

NIKE, NKE, Alagirisamy Venkatesh, Chief Operating Officer, COO, SEC Form 4, insider transaction, equity grant, restricted stock units, RSUs, stock options, executive compensation, Rule 10b5-1